ProterixBio, Inc. presenting at Biotech Showcase™ 2018
ProterixBio, Inc. will be attending Biotech Showcase™ 2018, to be held January 8-10th at the Hilton San Francisco Union Square. Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one… Read more »
November is COPD Awareness Month
ProterixBio is transforming chronic disease management through novel bioclinical analytics and digital health technologies. Our first area of focus is COPD. Join us this November to spread awareness about this chronic disease. Imagine breathing through a straw – that’s what it feels like to live with COPD. Every four minutes, someone dies of chronic obstructive… Read more »
ProterixBio presents COPD clinical study results at the European Respiratory Society International Congress
Billerica MA, September 12, 2017 – ProterixBio, Inc. today announced that results from a recent clinical study of subjects with chronic obstructive pulmonary disease (COPD) were presented this week at the European Respiratory Society International Congress. Algorithms based on combinations of protein biomarkers were successfully associated with measures of COPD disease activity such as shortness… Read more »